SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-024444
Filing Date
2022-08-31
Accepted
2022-08-31 08:15:34
Documents
16
Period of Report
2022-08-25
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 63608
2 ex10-2.htm EX-10.2 314584
3 ex10-3.htm EX-10.3 66395
4 ex99-1.htm EX-99.1 19441
5 ex99-1_001.jpg GRAPHIC 3247
  Complete submission text file 0001493152-22-024444.txt   706153

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE xtnt-20220825.xsd EX-101.SCH 3239
7 XBRL LABEL FILE xtnt-20220825_lab.xml EX-101.LAB 34916
8 XBRL PRESENTATION FILE xtnt-20220825_pre.xml EX-101.PRE 22797
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3664
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 221216303
SIC: 2836 Biological Products, (No Diagnostic Substances)